CARULLI, Nicola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.987
EU - Europa 8.664
AS - Asia 7.163
SA - Sud America 917
AF - Africa 153
Continente sconosciuto - Info sul continente non disponibili 87
OC - Oceania 17
Totale 33.988
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.643
SE - Svezia 2.337
SG - Singapore 2.228
CN - Cina 2.084
IT - Italia 2.081
GB - Regno Unito 1.851
HK - Hong Kong 827
BR - Brasile 685
DE - Germania 660
VN - Vietnam 610
FI - Finlandia 377
UA - Ucraina 332
BD - Bangladesh 328
TR - Turchia 318
FR - Francia 306
RU - Federazione Russa 250
KR - Corea 198
CA - Canada 163
IN - India 144
BG - Bulgaria 125
AR - Argentina 90
NL - Olanda 73
MX - Messico 56
ID - Indonesia 55
IQ - Iraq 52
JP - Giappone 47
IE - Irlanda 40
ZA - Sudafrica 39
AE - Emirati Arabi Uniti 34
PL - Polonia 31
CH - Svizzera 30
VE - Venezuela 30
CO - Colombia 28
EC - Ecuador 28
ES - Italia 28
TW - Taiwan 27
MY - Malesia 26
CZ - Repubblica Ceca 25
CR - Costa Rica 24
BE - Belgio 23
IL - Israele 22
PK - Pakistan 22
CL - Cile 20
MA - Marocco 19
PH - Filippine 19
UZ - Uzbekistan 19
HN - Honduras 18
SC - Seychelles 16
AT - Austria 15
EG - Egitto 14
KE - Kenya 14
SA - Arabia Saudita 14
PT - Portogallo 13
AU - Australia 12
JO - Giordania 11
NI - Nicaragua 11
PE - Perù 11
PY - Paraguay 11
SV - El Salvador 11
AZ - Azerbaigian 10
NP - Nepal 10
DO - Repubblica Dominicana 9
DZ - Algeria 9
IR - Iran 9
JM - Giamaica 9
RO - Romania 9
TT - Trinidad e Tobago 9
BO - Bolivia 8
EU - Europa 8
CW - ???statistics.table.value.countryCode.CW??? 7
ET - Etiopia 7
GT - Guatemala 7
LT - Lituania 7
PR - Porto Rico 7
TN - Tunisia 7
NG - Nigeria 6
OM - Oman 6
PA - Panama 6
SI - Slovenia 6
BB - Barbados 5
BH - Bahrain 5
GE - Georgia 5
GP - Guadalupe 5
LU - Lussemburgo 5
TH - Thailandia 5
UY - Uruguay 5
AL - Albania 4
AM - Armenia 4
AO - Angola 4
HU - Ungheria 4
KG - Kirghizistan 4
KZ - Kazakistan 4
NZ - Nuova Zelanda 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
UG - Uganda 4
BY - Bielorussia 3
DK - Danimarca 3
GR - Grecia 3
Totale 33.869
Salva come PNG Salva come JPEG
Città #
Ashburn 2.391
Stockholm 1.787
Singapore 1.505
Santa Clara 1.325
Southend 1.147
Fairfield 1.030
San Jose 827
Hong Kong 812
Woodbridge 790
Jacksonville 727
Chandler 721
Hefei 689
Houston 626
Dearborn 492
Ann Arbor 469
Chicago 382
Council Bluffs 382
Seattle 380
Wilmington 377
Beijing 375
Cambridge 361
Los Angeles 350
Nyköping 346
London 300
Helsinki 229
The Dalles 213
New York 197
Ho Chi Minh City 189
Seoul 185
Milan 183
Izmir 182
Hanoi 158
Salt Lake City 145
São Paulo 133
Princeton 130
Modena 126
Rome 126
San Diego 125
Sofia 120
Eugene 115
Des Moines 111
Columbus 104
Munich 103
Buffalo 99
Shanghai 98
Lauterbourg 96
Boardman 92
Tampa 88
Dallas 81
Grafing 73
Elk Grove Village 72
Moscow 69
Bologna 54
North Bergen 50
Orem 50
Bremen 48
Falls Church 46
Washington 46
Naples 45
Phoenix 43
Toronto 43
Turin 41
Sterling 37
Bari 33
Guangzhou 33
Brooklyn 32
Dublin 32
Tokyo 31
Turku 30
Baghdad 29
Kunming 29
Palermo 29
Atlanta 28
Florence 28
Frankfurt am Main 28
Montreal 28
Lancaster 27
Napoli 27
Miami 26
San Francisco 26
Chennai 25
Da Nang 25
Kent 25
Mexico City 25
Redwood City 25
Warsaw 24
Jakarta 22
Torino 22
Haiphong 21
Brussels 20
Catania 20
San Mateo 20
Brno 19
Nanjing 19
Amsterdam 18
Philadelphia 18
Rio de Janeiro 18
Verona 18
Denver 17
Manchester 17
Totale 23.650
Salva come PNG Salva come JPEG
Nome #
"Assay of HMG-CoA reductase activity in the evaluation of cholesterol synthesis in man". 2.066
Le basi scientifiche dell'approccio bio-psico-sociale. Indicazioni per l'acquisizione delle competenze mediche appropriate 1.741
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 553
Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: A possible compensatory mechanism. 484
Age-related changes in bile acid synthesis and hepatic nuclear receptor expression 458
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 453
Changes in bile acid synthesis in gallstone disease: cause, consequence or neither? 434
Review article: diabetes, genetics and ethnicity 432
Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. 427
Review article: the metabolic syndrome and non-alcoholic fatty liver disease 402
Characteristics of patients in a ward of Academic Internal Medicine. Implications for medical care, training programs and research 385
Correlation between plasma levels of 7alpha-hydroxy-4-cholesten-3-one and cholesterol 7alpha-hydroxylation rates in vivo in hyperlipidemic patients 368
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 366
Herpesvirus DNA is frequently detected in liver tissue from hepatitis C patients 365
Genetic polymorphisms in non-alcoholic fatty liver disease: Interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis 360
Growth of human herpesvirus 6 in HepG2 cells 355
In Vivo Degradation of Cholesterol to Bile Acids Is Reduced in Patients Receiving Parenteral Nutrition. 353
Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 341
Factors associated with gallstone disease in the MICOL experience 337
Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo. 336
Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.) 335
Liver and kidney foreign bodies granulomatosis in a patient with malocclusion, bruxism, and worn dental prostheses 332
ESTIMATION OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES 326
Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: Insights from evidence on hepatic cholesterol degradation and gallstone disease in humans 323
'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis 314
INCREASED 27-HYDROXYLATION OF CHOLESTEROL IN PRIMARY HYPERCHOLESTEROLEMIA 314
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 309
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 308
Advances in the comprehension of the pathophysiology of bile secretion 305
Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus - A prospective, double-blind, randomized study 303
Chicken or egg turned into head or belly 302
HEPATIC EXPRESSION OF NUCLEAR RECEPTORS AND BILIARY TRANSPOTERS IN HUMAN CHOLESTEROL GALLSTONE DISEASE. 302
Effects of acute changes of bile acid pool composition on biliary lipid secretion 300
Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question 300
Hepatic nuclear receptors in human cholelithiasis: A link with insulin resistance? 300
Effect of ursocholic acid on bile lipid secretion and composition 296
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 296
Bile acid structure and regulation of biliary protein secretion and composition in man 295
HEPATIC NUCLEAR RECEPTOR EXPRESSION AND REGULATION OF BILE ACID SYNTHESIS IN HUMANS 294
Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study 290
Determinants of bile secretion: effect of bile salt structure on bile flow and biliary cation secretion 290
Bile acid feeding and hepatic sterol metabolism: effect of deoxycholic acid. 288
Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans 284
Nuclear receptors and obstructive cholestasis in Humans: increased heaptic expression of short heterodimer partner : a protective response? 283
Review article: hyperlipidaemia and cardiovascular risk 272
Influence of age on bile acid synthesis: Role of hepatic expression of nuclear receptors 268
Intestinal solubilization, absorption, pharmacokinetics and bioavailability of chenodeoxycholic acid. 265
Influence of age and sex on serum concentrations of total dimeric activin A 264
Growth hormone plasma levels in nonalcoholic fatty liver disease 263
Effect of diabetic autonomic neuropathy on gallbladder kinetics in insulin dependent diabetic patients 261
Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease 260
Cholesterol metabolism in gallstone disease .Preliminary evidence from the analysis of circulating markers of sterol homeostasis 260
Fecal neutral steroids in normal conditions and in patients with polyps or cancer of the large bowel 259
Regolazione della sintesi di colesterolo e acidi biliari 257
Effect of small doses of deoxycholic acid on bile cholesterol saturation in patients with liver cirrhosis 257
Olanzapine-induced hypertriglyceridemia and Diabetes mellitus 252
TYPE 2 DIABETES AND CARDIOVASCULAR EVENTS : STUDY OF THE AMIN RISK FACTORS IN A LOCAL POPULATION OF PATIENTS 252
In vivo evaluation of cholesterol 7 alpha-hydroxylation in humans: effect of disease and drug treatment 249
Effects of different phenotypes of hyperlipoproteinemia and of treatment with fibric acid derivatives on the rates of cholesterol 7alpha-hydroxylation in humans 248
BILE CHANGES DURING TREATMENT WITH DEOXYCHOLIC-ACID - REPLY 244
Bile acid and hepatocyte death 240
Effect of aging on cholesterol 7 alpha-hydroxylation in humans 238
HCV and diabetes. A two-question-based reappraisal. 237
RISK FOR CARDIOVASCULAR EVENTS IN AN ITALIAN POPULATION OF PATIENTS WITH TYPE 2 DIABETES 237
EFFECT OF FISH OIL AND COCONUT OIL DIET ON THE LDL RECEPTOR ACTIVITY OF RAT LIVER PLASMA MEMBRANES. 236
Patogenesi della colelitiasi 233
Dysmetabolic changes associated with HCV: a distinct syndrome? 233
Fatty liver, carotid disease and gallstones: A study ofage-related associations 230
Effect of acute administration of bile acids on fatty acid composition of biliary phosphatidylcholine in man 227
Complications following percutaneous liver biopsy: a multicenter retrospective study on 68.276 biopsies 225
Statins and HCV: a complex issue 222
Invecchiamento e alterazioni dell’omeosatsi del colesterolo: studio dei livelli plasmatici degli steroli idrossilati come markers metabolici. 222
Cirrosi criptogenetiche. Un report di 5 pazienti 222
Tipologia dei ricoveri negli Ospedali Universitari: l'impatto sulle attività istituzionali 219
Malattie delle vie biliari 218
Prevalence rates of gallstone disease in Italy: the Chianciano population study 218
Regulation of bile acid synthesis in humans: studies on cholesterol 7alpha-hydroxylation 'in vivo' 217
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 217
EFFECT OF CHENODEOXYCHOLIC ACID AND URSODEOXYCHOLIC ACID ADMINISTRATION ON ACYL-COA - CHOLESTEROL ACYLTRANSFERASE ACTIVITY IN HUMAN LIVER 217
Epidemiologia e storia naturale dell'epatopatia steatosica non alcolica 216
RISK FOR CARDIOVASCULAR EVENTS IN A LOCAL POPULATION OF DIABETIC PATIENTS 216
Patogenesi ed epidemiologia della steatosi epatica e della steatoepatite non alcolica (NASH). 213
Hepatitis C and steatosis: a reappraisal 212
HEPATIC NUCLEAR RECEPTOR EXPRESSION AND REGULATION OF BILE ACID SYNTHESIS IN HUMANS 212
Cholestatic icterus: is there still a role for the clinic? 210
The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease 208
Reply 207
Acute abdomen associated with schistosomiasis of the appendix 207
Structure and concentartion of differenty fatty acid (FFAS) affect steatosis extent and apoptosis in hepatocytes coltures 206
Concurrent non-alcoholic steatohepatitis and psoriasis. Report of three cases from the POLI.ST.E.N.A. study. 206
Ursodeoxycholic acid improves liver tests in chronic hepatitis - Results of a randomised controlled trial 205
Nuove prospettive terapeutiche con acidi biliari. 202
Effects of bile acid pool composition on hepatic metabolism of cholesterol in man 201
Chronic hepatopathies: from cryptogenetics to multiple factors 197
DIABETES AND CARDIOVASCULAR EVENTS: USEFULNESS AND LIMITS OF RISK FUNCTIONS 197
Invecchiamento ed alterazioni dell’omeostasi del colesterolo: studi dei livelli plasmatici degli steroli idrossilati come markers metabolici. 196
Effect of taurohyodeoxycholic acid on biliary lipid secretion in man: preliminary report. 195
Dietary cholesterol absorption in cirrhosis: the role of total and individual bile acid pool size. 193
Risk for cardiovascular events in a local population of diabetic patients 193
Colelitiasi sintomatica: affiorano dubbi sulla necessita' dell'intervento. 192
Totale 31.028
Salva come PNG Salva come JPEG
Categoria #
all - tutte 121.689
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.689
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.419 0 0 0 0 54 114 155 118 229 125 365 259
2022/20232.135 235 218 135 210 241 379 59 185 270 31 89 83
2023/20241.387 72 68 66 108 267 131 182 178 45 49 84 137
2024/20254.750 181 92 104 315 988 599 381 219 442 176 550 703
2025/202611.449 514 441 706 1.119 2.023 735 1.139 377 2.575 804 580 436
2026/20273.512 236 587 837 1.671 181 0 0 0 0 0 0 0
Totale 33.988